Hospital-Based and Home-Based Resistance Training in Adult Congenital Heart Disease
Key facts
- Who runs it
- Hacettepe University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 33 people, planned
- Started
- 5 Jan 2025
- Planned end
- 5 Nov 2025
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Hospital-Based Resistance Training
- Home-Based Resistance Training
- Record updated
- 8 November 2024
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Diagnosis of congenital heart disease
- Aged between 18 and 45 years
- Being informed about the study and providing written consent to participate
- Clinical stability has been achieved in the patients
- No changes in ongoing medication treatment that negatively affect clinical stability
Who cannot take part
- Having additional cardiovascular, neurological, orthopedic, or any other systemic diseases
- Being classified as high risk (severe systolic dysfunction, moderate/severe elevated pulmonary artery pressure, significant arrhythmic burden, malignant arrhythmia, etc.)
- Undergoing a surgery other than heart surgery
- Not suitable for cognitive, psychological, and mental assessments
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Congenital heart disease (CHD) is defined as functional or anatomical abnormalities of the heart and major intrathoracic vessels present at birth. Impaired responses to exercise in individuals with CHD reduce exercise capacity and increase long-term mortality risk. Today, the growing population of adults with congenital heart disease (ACHD) faces chronic issues stemming from congenital abnormalities, along with muscle strength loss and a decline in activities of daily living. Once the planned treatments in this project proposal are implemented and data are obtained (especially if these data support the hypotheses), the treatment protocols applied in this study and their effects will be considered alongside the current treatment plans for individuals with CHD who experience muscle strength loss and disease-related impairment. With new treatment programs, this study aims to reduce disease-related muscle strength loss, improve disease-related outcomes, and enhance quality of life.
The 3 groups in the trial
- Hospital-Based Resistance Training GroupTreatment being tested
Participants will undergo resistance training using a weight training station and elastic equipment (elastic bands and tubes).
Treatment: Hospital-Based Resistance Training
- Home-Based Resistance Training GroupTreatment being tested
Participants will undergo resistance training at home using elastic equipment (elastic bands and tubes).
Treatment: Home-Based Resistance Training
- Control GroupNo study treatment, for comparison
No training will be provided to the participants.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparison of the Effects of Hospital-Based and Home-Based Resistance Training in Individuals with Adult Congenital Heart Disease
- Fit questions
- Built from NCT06680973, who can take part
- Record updated
- 8 November 2024